At the Limits Multiple Sclerosis 2023

Multiple Sclerosis at the Limits is supported by way of grants or sponsorship from the pharmaceutical industry. Our supporters have no involvement in the organisation of this event, or the selection of speakers or topics which are handled entirely independently by the event Chairs. Supporters are invited to send a delegation of senior company representatives to attend, and their role is simply to continue building the crucial understanding between academia and industry in a scientific setting. Full disclosure of contacted supporters will appear on the event website and be available at the venue during the event.

• + Include: 13 videos + 1 pdf, size: 5.61 GB

+ Sample video: contact me for sample video

+ Topics:

• Multiple Sclerosisÿat the Limits.pdf
• Associate Professor M Isabel Leite – Long-term treatment of NMOSD – what do we need to know to make meaningful decisions-.mp4
• Debate – DMT’s for all at diagnosis.mp4
• Dirk Smeets – Demystifying AI and embedding it into clinical practice.mp4
• Dr Arman Eshaghi – Redefining disease phenotyping in MS – basic science.mp4
• Panel discussion – Emerging therapies in MS.mp4
• Professor Alberto Ascherio – EBV in MS – still in focus, or soon forgotten (again)-.mp4
• Professor Anat Achiron – DMT in newly diagnosed people with MS – coaching or coaxing.mp4
• Professor David Baker – Beyond B-Cells – selective targeting of B-cell subpopulations.mp4
• Professor Francisco J. Quintana – Cell-Cell signalling pathways- microglia and activated astrocytes.mp4
• Professor Gavin Giovannoni – Redefining disease cell-typing in MS – clinical.mp4
• Professor Jacqueline Palace – Long-term treatment of MOG AD – what do we need to know to make meaningful decisions.mp4
• Professor Magd Zakaria – Treating MS Globally – the challenge of equity in MS care.mp4
• Univ. Prof. Dr. Med. Heinz Wiendl – Immunopathogenic Mechanisms.mp4